FGEMX
Price
$109.68
Change
+$0.41 (+0.38%)
Updated
Dec 20 closing price
MOGLX
Price
$9.14
Change
+$0.09 (+0.99%)
Updated
Dec 20 closing price
Ad is loading...

FGEMX vs MOGLX

Header iconFGEMX vs MOGLX Comparison
Open Charts FGEMX vs MOGLXBanner chart's image
Fidelity Advisor Communication ServicesM
Price$109.68
Change+$0.41 (+0.38%)
VolumeN/A
CapitalizationN/A
Gabelli Media Mogul
Price$9.14
Change+$0.09 (+0.99%)
VolumeN/A
CapitalizationN/A
FGEMX vs MOGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FGEMX vs. MOGLX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEMX is a Hold and MOGLX is a Hold.

FUNDAMENTALS
Fundamentals
FGEMX has more cash in the bank: 1.71B vs. MOGLX (4.06M). MOGLX pays higher dividends than FGEMX: MOGLX (0.92) vs FGEMX (0.00). FGEMX was incepted earlier than MOGLX: FGEMX (6 years) vs MOGLX (8 years). FGEMX is a more actively managed with annual turnover of: 45.00 vs. MOGLX (25.00). FGEMX has a lower initial minimum investment than MOGLX: FGEMX (0) vs MOGLX (5000). FGEMX annual gain was more profitable for investors over the last year : 28.13 vs. MOGLX (3.38). FGEMX return over 5 years is better than : 70.34 vs. MOGLX (-18.05).
FGEMXMOGLXFGEMX / MOGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD27.7132.0161,374%
Front LoadN/AN/A-
Min. Initial Investment05000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B4.06M42,219%
Annual Yield % from dividends0.000.92-
Returns for 1 year28.133.38832%
Returns for 3 years23.42-22.07-106%
Returns for 5 years70.34-18.05-390%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEVI17.390.74
+4.44%
Levi Strauss & Co
EQX5.160.10
+1.98%
Equinox Gold Corp
BOC14.32-0.08
-0.56%
Boston Omaha Corp
CTMX1.09-0.01
-0.91%
CytomX Therapeutics
META585.25-10.32
-1.73%
Meta Platforms